Patient Acquisition Challenges in Cell and Gene Therapy

Drug Pricing in Japan: The Changing Landscape and Future Prospects

The Woes and Wins of CAR-T Manufacturing: Lessons from Abecma and Carvykti

Impact of the Institute for Clinical and Economic Review (ICER) on Cell and Gene Therapy Pricing and Access

Insights from Leading CNS Players

CNS Year in Review: Novel Modalities

One-Hit Wonders: The Second Product Problem in Biotech

CNS Year in Review: Going Digital

Reflections from Harvard Business School’s D^3 Catalyst Women’s Health Workshop 2023

CNS Year in Review: Introduction and Large CNS Diseases

Alumni Spotlight: Brittany Carroll, Vice President and Therapy Area Lead at Blueprint Medicines

AAOS 2023: Implementing and Scaling New Technologies in a “Post-COVID World”

Task Shifting in Reimagined Care Models and the Role of Technology

AI in Healthcare: Implications at the Molecular, System, and Patient Level

Is the Healthcare Industry Meeting the Rising Expectations of Consumers?

The Humira Biosimilars Have Arrived! Will They Make a Difference?

Growing Pains in Cell and Gene Therapy

Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook

Maturation of Modalities and Targeting Strategies in Oncology: A Review of Recent and Upcoming Approvals

Allogeneic Cell Therapy: ASH 2022 Takeaways and Future Outlook

Category: BioPharma

Patient Acquisition Challenges in Cell and Gene Therapy

Drug Pricing in Japan: The Changing Landscape and Future Prospects

The Woes and Wins of CAR-T Manufacturing: Lessons from Abecma and Carvykti

Impact of the Institute for Clinical and Economic Review (ICER) on Cell and Gene Therapy Pricing and Access

Insights from Leading CNS Players

CNS Year in Review: Novel Modalities

One-Hit Wonders: The Second Product Problem in Biotech

CNS Year in Review: Going Digital

Reflections from Harvard Business School’s D^3 Catalyst Women’s Health Workshop 2023

CNS Year in Review: Introduction and Large CNS Diseases

Alumni Spotlight: Brittany Carroll, Vice President and Therapy Area Lead at Blueprint Medicines

AAOS 2023: Implementing and Scaling New Technologies in a “Post-COVID World”

Task Shifting in Reimagined Care Models and the Role of Technology

AI in Healthcare: Implications at the Molecular, System, and Patient Level

Is the Healthcare Industry Meeting the Rising Expectations of Consumers?

The Humira Biosimilars Have Arrived! Will They Make a Difference?

Growing Pains in Cell and Gene Therapy

Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook

Maturation of Modalities and Targeting Strategies in Oncology: A Review of Recent and Upcoming Approvals

Allogeneic Cell Therapy: ASH 2022 Takeaways and Future Outlook